Novel Drug Delivery Systems companies

Key Novel Drug Delivery Systems Market Players:

The market for novel drug delivery systems (NDDS) contains fierce competition between multinational pharmaceutical and biotech companies. Johnson & Johnson and Pfizer are two key players that capitalize on a robust R&D pipeline with advanced delivery technologies. Companies emerging from India and Malaysia have offered an NDDS amid the burgeoning demand for affordable generic NDDS. Strategic efforts such as collaboration with health care providers and using contract manufacturing while targeting a biologics expansion have contributed to their position in the market. Ongoing regulatory approvals are expanding the market, and government support has catalyzed innovation.

Here is a list of key players operating in the global novel drug delivery systems market:

• Johnson & Johnson
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
• Pfizer Inc.
• Novartis AG
• Teva Pharmaceutical Industries
• AstraZeneca plc
• Takeda Pharmaceutical Company
• Samsung Biologics
• Dr. Reddy's Laboratories
• GlaxoSmithKline plc
• Baxter International Inc.
• CSL Limited
• Sun Pharmaceutical Industries
• Biocon Limited
• Sandoz International GmbH
• F. Hoffmann-La Roche AG
• Boehringer Ingelheim GmbH
• Mitsubishi Tanabe Pharma
• Cipla Limited
• UCB Pharma
• Hovid Berhad